United States · Bill · S
S. 3364 (117th)
Respiratory Syncytial Virus (RSV) Impact Act
Introduced
9 December 2021
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
21 April 2025
Summary
Respiratory Syncytial Virus (RSV) Impact Act This bill requires the Department of Health and Human Services to contract with the National Academy of Sciences for a study on respiratory syncytial virus (RSV) transmission in schools and day cares. In particular, the study must evaluate the impact of RSV on the economy, including through parents' absences from work. RSV is a common respiratory virus that typically causes mild, cold-like symptoms although it may be more serious for infants, older adults, and other vulnerable populations.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 9 December 2021
Introduced in Senate (PDF)
Introduced in Senate · EN · 9 December 2021
Introduced in Senate
summary · EN · 9 December 2021
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/senate-bill/3364
- Open data entity: https://api.congress.gov/v3/bill/117/s/3364